Antiplatelet medicine to prevent heart events after brain bleed
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had your first ever brain bleed (not from a head injury or other known cause).
- You are at least 18 years old.
- Your stroke symptoms started at least 24 hours ago but no more than 3 months ago.
- Your brain bleed was confirmed by a CT or MRI scan.
- You are alive and stable 24 hours after the brain bleed.
- You are not currently taking any blood thinners (including aspirin, clopidogrel, warfarin, or similar).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
This Phase 3 study tests whether a blood thinner (apixaban) can help prevent another stroke and support recovery after you’ve had a brain bleed. You would be assigned to a treatment group, and the study checks safety and whether strokes can be reduced without causing dangerous bleeding.
This clinical trial tests whether a medication called cilostazol can help the body reabsorb a brain bleed (intracerebral hemorrhage) more quickly. It is for adults with a small bleed in a specific part of the brain (thalamus or basal ganglia) who are otherwise in good health.
This trial tests a combination of two blood thinners (antiplatelet drugs) to see if they work better than one in people who had a mild stroke caused by a narrowed artery in the brain. If you had a recent first stroke and are otherwise healthy, you may be able to join.
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
Hear when a new Intracerebral Haemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.